TGS


MHRA approves remibrutinib for adults with chronic spontaneous urticaria

MHRA approves remibrutinib for adults with chronic spontaneous urticaria

https://www.gov.uk/government/news/mhra-approves-remibrutinib-for-adults-with-chronic-spontaneous-urticaria

seen at 16:51, 6 August in News and communications.